about
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the ...
Read More
126.55
0.08
(0.06%)
761.2K
XNYS Volume
XNYS 29 Aug, 2025 5:30 PM (EDT)
High Financial Strength
Mid Valuation
Technically Moderately Bullish
Strong Performer, Getting Expensive
These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying.
View Similar
Embed DVM
Novartis AG - ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..